ID: ALA4550608

Max Phase: Preclinical

Molecular Formula: C30H32N6O4

Molecular Weight: 540.62

Molecule Type: Unknown

Representations

Canonical SMILES:  CCCCc1nc(C(C)C)c(Cc2nc(C)no2)c(=O)n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1

Standard InChI:  InChI=1S/C30H32N6O4/c1-5-6-11-25-32-27(18(2)3)24(16-26-31-19(4)34-39-26)29(37)36(25)17-20-12-14-21(15-13-20)22-9-7-8-10-23(22)28-33-30(38)40-35-28/h7-10,12-15,18H,5-6,11,16-17H2,1-4H3,(H,33,35,38)

Standard InChI Key:  KIYVBGBMCNENMR-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 540.62

Molecular Weight (Monoisotopic): 540.2485

AlogP: 5.05

#Rotatable Bonds: 10

Polar Surface Area: 132.70

Molecular Species: ACID

HBA: 9

HBD: 1

#RO5 Violations: 2

HBA (Lipinski): 10

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 5.91

CX Basic pKa: 1.83

CX LogP: 5.94

CX LogD: 5.00

Aromatic Rings: 5

Heavy Atoms: 40

QED Weighted: 0.26

Np Likeness Score: -1.21

References

1. Choung W, Yang D, Kim H, Choi H, Lee BR, Park M, Jang SM, Lim JS, Kim WS, Kim KH, Chin J, Jung K, Lee G, Hong E, Jang TH, Joo J, Hwang H, Myung J, Kim SH..  (2019)  Discovery of BR102375, a new class of non-TZD PPARγ full agonist for the treatment of type 2 diabetes.,  29  (16): [PMID:31253533] [10.1016/j.bmcl.2019.06.027]

Source

Source(1):

• Scientific Literature